T-CYPHER BIO LIMITEDActive

Company number 09843076Private limited companyIncorporated 2015

Key figures

−£21,613,340-42.3%
Net assets 2025
-30 m-20 m-10 m010 m201920212022202320242025

Like most small UK companies, T-CYPHER BIO LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 m20 m30 m201920212022202320242025
Filed accounts2019–2025
20212022202320242025
Cash at bank and in hand2,397,0641,289,8575,858,18911,874,8595,201,966
Total assets3,153,8262,521,3967,140,19914,402,2057,893,612
Total liabilities6,123,0628,634,88517,679,66429,593,79829,506,952
Net assets / total equity-2,252,415-5,427,839-9,809,336-15,191,593-21,613,340
Average number of employees8212300

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: T-CYPHER BIO LIMITED

Company

T-CYPHER BIO LIMITED is a private limited company registered with Companies House under company number 09843076. It was incorporated on 27 Oct 2015. Its status is active. The registered office is in Abingdon (OX14). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110), other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts. Net assets were −£21,613,340, down 42.3% on the previous year. Cash at bank and in hand was £5,201,966. Total assets were £7,893,612 and total liabilities £29,506,952. The company had an average of 0 employees. Figures are available for 6 financial years (2019–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 9 Nov 2026.